
Loading, please wait...

Loading, please wait...

This randomised controlled trial compared higher-protein with medium-protein delivery in critically ill adults while keeping total energy delivery similar. The study addressed a growing area of interest in critical-care nutrition: whether protein dose, independent of calories, influences recovery and functional outcomes. Patients were assigned to a higher-protein target of approximately 1.8 g/kg/day or a medium-protein target of about 0.9 g/kg/day. The study also considered the interaction between nutrition and early rehabilitation. The findings are best interpreted as part of an evolving evidence base rather than proof that every critically ill patient should receive a high protein dose immediately. Timing, disease phase, organ function, renal replacement, tolerance and mobilisation all affect how protein is handled. This directly aligns with CritiCARE's dedicated nutrition and metabolism sessions on protein delivery, sarcopenia and early rehabilitation. For HCPs, the practical lesson is that protein prescription should be deliberate and monitored rather than driven by a single universal target. The study also highlights a crucial concept in modern ICU care: nutrition and mobilisation should be considered together. Prescribing protein without a plan for recovery and functional rehabilitation may not capture the full clinical objective.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This randomised controlled trial compared higher-protein with medium-protein delivery in critically ill adults while keeping total energy delivery similar. The study addressed a growing area of interest in critical-care nutrition: whether protein dose, independent of calories, influences recovery and functional outcomes. Patients were assigned to a higher-protein target of approximately 1.8 g/kg/day or a medium-protein target of about 0.9 g/kg/day. The study also considered the interaction between nutrition and early rehabilitation. The findings are best interpreted as part of an evolving evidence base rather than proof that every critically ill patient should receive a high protein dose immediately. Timing, disease phase, organ function, renal replacement, tolerance and mobilisation all affect how protein is handled. This directly aligns with CritiCARE's dedicated nutrition and metabolism sessions on protein delivery, sarcopenia and early rehabilitation. For HCPs, the practical lesson is that protein prescription should be deliberate and monitored rather than driven by a single universal target. The study also highlights a crucial concept in modern ICU care: nutrition and mobilisation should be considered together. Prescribing protein without a plan for recovery and functional rehabilitation may not capture the full clinical objective.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back